Source: Business Wire

Press Release: Blade Therapeutics : Blade Therapeutics to Participate in "Drug Development in Pulmonary Medicine" Panel Discussion at 2022 BTIG Biotechnology Conference

SAN FRANCISCO--(BUSINESS WIRE)-- #BTIG--Blade Therapeutics to participate in "Drug Development in Pulmonary Medicine" panel discussion on August 9 at the 2022 BTIG Biotechnology Conference

Read full article »
Blade Therapeutics's Competitors | Blade Therapeutics's News | Blade Therapeutics's Financials
Stay up-to-date with the latest news on Blade Therapeutics
Est. Annual Revenue
$5.0-25M
Est. Employees
25-100
Wendye Robbins's photo - President & CEO of Blade Therapeutics

President & CEO

Wendye Robbins

CEO Approval Rating

97/100

Read more
Stay up-to-date with the latest news on Blade Therapeutics